AnalystsMadison El-SaadiMadison El-Saadi's Stock Forecasts
AnalystsMadison El-Saadi
Sectors:
Analyst Ranking
Top 27%
#1413 out of 5256 analysts
Average Return
+24.52%
Win Rate
67%10 out of 15
Risk vs Reward
Poor
Good
Madison El-Saadi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Capricor Therapeutics IncCAPR | +236.05% | $10.18 | $34.21 | 2025-06-26 - 2026-04-20 | Strong Buy |
Axsome Therapeutics IncAXSM | +59.14% | $118.57 | $188.69 | 2025-10-01 - 2026-04-20 | Strong Buy |
Vanda Pharmaceuticals IncVNDA | +57.43% | $4.44 | $6.99 | 2025-11-05 - 2026-04-20 | Strong Buy |
Eton Pharmaceuticals IncETON | +33.54% | $18.93 | $25.28 | 2025-05-16 - 2026-04-20 | Strong Buy |
Capricor Therapeutics IncCAPR | +28.85% | $26.55 | $34.21 | 2025-12-15 - 2026-04-20 | Strong Buy |
Madison El-Saadi Analyst Color
Get additional color on Madison El-Saadi's coverage of popular stocks
Madison El-Saadi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Eton Pharmaceuticals IncETON | 4 | Strong Buy | $31.00 | +22.63% | Maintains | a month ago |
Capricor Therapeutics IncCAPR | 3 | Strong Buy | $63.00 | +84.16% | Maintains | a month ago |
Arrowhead Pharmaceuticals IncARWR | 1 | Strong Buy | $101.00 | +45.85% | Maintains | 3 months ago |
Vanda Pharmaceuticals IncVNDA | 2 | Strong Buy | $14.00 | +100.29% | Maintains | 4 months ago |
Wave Life Sciences LtdWVE | 4 | Strong Buy | $37.00 | +388.13% | Maintains | 4 months ago |
Axsome Therapeutics IncAXSM | 1 | Strong Buy | $179.00 | -5.14% | Initiates Coverage On | 7 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.